Dose-dependent effects of eltrombopag iron chelation on platelet formation
Abstract: Iron deficiency is associated with thrombocytosis in patients, although thrombocytopenia can occur in cases of severe iron deficiency anemia. Eltrombopag (EP), a thrombopoietic agent approved for immune thrombocytopenia, also acts as an iron chelator. Our study demonstrates that megakaryoc...
Furkejuvvon:
| Váldodahkkit: | , , , , , , , |
|---|---|
| Materiálatiipa: | Artigo |
| Giella: | Inglês |
| Almmustuhtton: |
Elsevier
2025-05-01
|
| Ráidu: | Blood Vessels, Thrombosis & Hemostasis |
| Liŋkkat: | http://www.sciencedirect.com/science/article/pii/S2950327225000178 |
| Fáddágilkorat: |
Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!
|